Paris-based Bioaxial grabs 1.9 mln euros in Series A funds

Paris-based Bioaxial has closed 1.9 million euros in Series A funding. Investors included Amorçage Technologique Investissement, Inserm Transfert Initiative and Viveris Management. Bioaxial is a provider of high resolution imaging instruments for the life sciences and healthcare R&D sector.

North AmericaUSBriefs